These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 19031359)

  • 1. Nuchal translucency thickness in euploid fetuses: is two millimeters too risky?
    Fink M; Sheiner E; Sheizaf B; Hershkovitz R; Bashiri A; Mazor M; Wiznitzer A
    Am J Perinatol; 2009 Apr; 26(4):303-7. PubMed ID: 19031359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A significant linear association exists between nuchal translucency thickness and adverse perinatal outcome in euploid fetuses.
    Sheizaf B; Sheiner E; Fink M; Hershkovitz R; Mazor M; Wiznitzer A
    J Matern Fetal Neonatal Med; 2009 Jun; 22(6):479-84. PubMed ID: 19479642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy outcome of euploid fetuses with increased nuchal translucency: how bad is the news?
    Maymon R; Weinraub Z; Herman A
    J Perinat Med; 2005; 33(3):191-8. PubMed ID: 15914340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population.
    Westin M; Saltvedt S; Almström H; Grunewald C; Valentin L
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):150-8. PubMed ID: 17211897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy after bariatric surgery is not associated with adverse perinatal outcome.
    Sheiner E; Levy A; Silverberg D; Menes TS; Levy I; Katz M; Mazor M
    Am J Obstet Gynecol; 2004 May; 190(5):1335-40. PubMed ID: 15167839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstetric characteristics and perinatal outcome of pregnancies with uterine leiomyomas.
    Sheiner E; Bashiri A; Levy A; Hershkovitz R; Katz M; Mazor M
    J Reprod Med; 2004 Mar; 49(3):182-6. PubMed ID: 15098887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic bleeding during the second half of pregnancy as a risk factor for adverse perinatal outcome.
    Harlev A; Levy A; Zaulan Y; Koifman A; Mazor M; Wiznitzer A; Faizayev E; Sheiner E
    J Matern Fetal Neonatal Med; 2008 May; 21(5):331-5. PubMed ID: 18446661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical evaluation and pregnancy outcome of euploid fetuses with increased nuchal translucency.
    Maymon R; Herman A
    Clin Genet; 2004 Nov; 66(5):426-36. PubMed ID: 15479188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male gender as a favorable prognostic factor in pregnancies with enlarged nuchal translucency.
    Timmerman E; Pajkrt E; Bilardo CM
    Ultrasound Obstet Gynecol; 2009 Oct; 34(4):373-8. PubMed ID: 19618399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is nuchal translucency a useful aneuploidy marker in fetuses with crown-rump length of 28-44 mm?
    Grande M; Solernou R; Ferrer L; Borobio V; Jimenez JM; Bennasar M; Soler A; Borrell A
    Ultrasound Obstet Gynecol; 2014 May; 43(5):520-4. PubMed ID: 24006271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age.
    Mula R; Goncé A; Bennásar M; Arigita M; Meler E; Nadal A; Sánchez A; Botet F; Borrell A
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):34-41. PubMed ID: 21837766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do early pregnancy ultrasound measurements correlate with fetal nuchal translucency at 11-14 weeks?
    Prefumo F; Condous G; Papageorghiou A; Thilaganathan B; Bourne T
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):628-31. PubMed ID: 16514621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal mortality: a sporadic event or a recurrent catastrophe?
    Weintraub AY; Rozen A; Sheiner E; Levy A; Press F; Wiznitzer A
    Arch Gynecol Obstet; 2009 Mar; 279(3):299-303. PubMed ID: 18584187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early fetal size and growth as predictors of adverse outcome.
    Pedersen NG; Figueras F; Wøjdemann KR; Tabor A; Gardosi J
    Obstet Gynecol; 2008 Oct; 112(4):765-71. PubMed ID: 18827118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of peripartum fever in women undergoing vaginal deliveries.
    Bensal A; Weintraub AY; Levy A; Holcberg G; Sheiner E
    Am J Perinatol; 2008 Oct; 25(9):567-72. PubMed ID: 18756433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation.
    Maiz N; Valencia C; Emmanuel EE; Staboulidou I; Nicolaides KH
    Obstet Gynecol; 2008 Sep; 112(3):598-605. PubMed ID: 18757658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acoustic output as measured by thermal and mechanical indices during fetal nuchal translucency ultrasound examinations.
    Sheiner E; Abramowicz JS
    Fetal Diagn Ther; 2009; 25(1):8-10. PubMed ID: 19077424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal obesity as an independent risk factor for caesarean delivery.
    Sheiner E; Levy A; Menes TS; Silverberg D; Katz M; Mazor M
    Paediatr Perinat Epidemiol; 2004 May; 18(3):196-201. PubMed ID: 15130159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.